Free Trial

ALX Oncology (ALXO) SEC Filings & 10K Form

ALX Oncology logo
$0.55 +0.04 (+8.76%)
Closing price 04/15/2025 04:00 PM Eastern
Extended Trading
$0.54 -0.01 (-1.87%)
As of 04/15/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent ALX Oncology SEC Filings

DateFilerForm TypeView
03/18/2025
3:45 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
3:41 PM
ALX Oncology (Issuer)
Lettmann Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2025
4:26 PM
ALX Oncology (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/21/2025
3:20 PM
ALX Oncology (Issuer)
Lettmann Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
3:23 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:27 PM
ALX Oncology (Issuer)
Takimoto Chris H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:29 PM
ALX Oncology (Issuer)
GOODMAN COREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:30 PM
ALX Oncology (Issuer)
Garland J. Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:32 PM
ALX Oncology (Issuer)
Hemrajani Rekha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:14 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:17 PM
ALX Oncology (Issuer)
Shantharam Harish (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/23/2025
5:19 PM
ALX Oncology (Issuer)
Shantharam Harish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:22 PM
ALX Oncology (Issuer)
Klencke Barbara (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/23/2025
5:24 PM
ALX Oncology (Issuer)
Klencke Barbara (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:25 PM
ALX Oncology (Issuer)
Takimoto Chris H (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/23/2025
5:07 PM
ALX Oncology (Issuer)
Lettmann Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:09 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
5:11 PM
ALX Oncology (Issuer)
Sandler Alan B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2025
7:01 AM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2025
3:39 PM
ALX Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
01/17/2025
3:41 PM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
3:10 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:43 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:46 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2024
3:12 PM
ALX Oncology (Subject)
Form SC TO-I/A
12/27/2024
3:05 PM
ALX Oncology (Subject)
HBM Healthcare Investments Ltd. (0001232258) (Filed by)
Form SCHEDULE 13G
12/06/2024
10:33 AM
ALX Oncology (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
12/02/2024
3:06 PM
ALX Oncology (Subject)
Form SC TO-I
11/14/2024
6:22 PM
ALX Oncology (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SC 13G/A
11/14/2024
5:58 PM
ALX Oncology (Subject)
Vivo Capital Fund IX, L.P. (Filed by)
Form SC 13G/A
11/14/2024
2:02 PM
ALX Oncology (Subject)
Cormorant Asset Management, LP (Filed by)
Form SC 13G/A
11/14/2024
7:03 AM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2024
3:14 PM
ALX Oncology (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G/A
10/04/2024
8:00 AM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2024
3:00 PM
ALX Oncology (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13G
08/16/2024
4:05 PM
ALX Oncology (Issuer)
Lettmann Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:06 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:08 PM
ALX Oncology (Issuer)
GARCIA PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:09 PM
ALX Oncology (Issuer)
Randolph Sophia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
4:10 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2024
3:17 PM
ALX Oncology (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
Form SC 13G
Is it CRAZY to still want reliable profits, despite this market? (Ad)

Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who – while everyone else watched their retirement get cut in half in 2008... Performed 103% better than the market. And the one who crushed the market by 4X during the COVID meltdown.

Click here to access this emergency tariff briefing now.
08/07/2024
4:23 PM
ALX Oncology (Issuer)
Sandler Alan B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:22 PM
ALX Oncology (Issuer)
Sandler Alan B. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/06/2024
3:45 PM
ALX Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2024
3:23 PM
ALX Oncology (Subject)
Pons Jaume (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/09/2024
3:09 PM
ALX Oncology (Issuer)
Pinto Shelly (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
3:39 PM
ALX Oncology (Issuer)
GARCIA PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2024
8:00 AM
ALX Oncology (Issuer)
GARCIA PETER S (Reporting)
Form 4/A
06/17/2024
6:29 AM
ALX Oncology (Issuer)
GARCIA PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:46 PM
ALX Oncology (Issuer)
Garland J. Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:49 PM
ALX Oncology (Issuer)
Hemrajani Rekha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
3:42 PM
ALX Oncology (Issuer)
GOODMAN COREY S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:14 PM
ALX Oncology (Subject)
Pons Jaume (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2024
3:10 PM
ALX Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2024
4:31 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
3:49 PM
ALX Oncology (Issuer)
Pons Jaume (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2024
3:34 PM
ALX Oncology (Subject)
Pons Jaume (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:ALXO) was last updated on 4/16/2025 by MarketBeat.com Staff
From Our Partners